Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Masitinib mesilate

EU orphan designation number: EU/3/16/1722   
Active ingredient: Masitinib mesilate
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: AB Science
3, avenue George V, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/081/16 (2016)5629 of 29/08/2016